SOLUFOS

Specifications

Therapeutic area

Antibiotics

Manufacturer

TOLL MANUFACTURING SERVICES, S.L., Spain (Packing: EDEFARM, S.L., Spain)

Applicant company

Cross Pharmaceutical Joint Stock Company

Visa Number

VN-22523-20

Issuing date

26/06/2020

Applicant company

Orioled Hub SIA

Active ingredient

Fosfomycin calcium

Content

500mg

Indication

Solufos is indicated for the treatment of the following severe infections:
Deep skin infections, cystitis, otitis media, sinusitis, stye, dacryocystitis, infectious enteritis.

Dosage

Adults: 2 - 3 g fosfomycin 3 or 4 times daily.
Children: 40 - 120 mg fosfomycin/kg 3 or 4 times daily.
Dosage can be adjusted according to age and clinical condition.

Shelf life

48

Dosage Form

Hard capsule

Package

Box of 1 bottle of 24 capsules